Cannabis

Global spending on legal cannabis is expected to grow 230% to $31.3% billion in 2022 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. The research projects a majority of that, nearly $23.4 billion will come from the United States. In context of more states voting in favor of marijuana use legalization and business interest sparking across the board, that definitely would make sense.

In the year through January 11, 2019, the United States Marijuana Index, fell 20.7%, as compared to about 6.5% loss seen by the S&P 500. Given that is not exactly an apples to apples comparison, but it does make a case to at least investigate investments in marijuana stocks. (May 6, 2019, Mrinalini Krishna, Investopedia)

Canadian cannabis stocks have been less appealing to investors because of volatility caused by the COVID-19 crisis. However, the industry still has potential and in the next few years, the cannabis sector will truly live to its potential. Here are some stocks showing a lot of potentials. Aurora rightsizing as...
In the last two years, the cannabis industry has faced a myriad of challenges but the COVID-19 pandemic has brought new realities for Canadian cannabis stocks. Cannabis stocks experienced a surge in demand for pot during the COVID-19 lockdown leading to several operators reporting exceptional results in the recent...
Canadian cannabis stocks have been facing a myriad of challenges since the legalization of marijuana in the country. One of the biggest challenges for operators has been regulatory issues with Health Canada and slow licensing of retail dispensaries. The slow process of licensing dispensaries has hamstrung operators and the...
Canadian Cannabis stocks have had a torrid past year but amid the coronavirus pandemic there has been a surge in demand and some of the operators have reported exceptional results. In recent weeks several Canadian cannabis stocks have been hot owing to an exceptional first quarter of 2020. Although...
When 2018 there was much expectation and most Canadian cannabis stocks began positioning themselves to reap the gains of the nascent sector. Most companies have been struggling with cash problems and although the coronavirus pandemic might have halted operations several operators have reported an increase in sales in the...
The Canadian cannabis sector is crowded but there is still potential for large-cap and deep-pocketed Canadian cannabis stocks. The industry has faced serious challenges in the past year and the coronavirus pandemic just worsened prospects for some of the operators. When Canada legalized pot most of the operators embarked on...
It has been a difficult year for Canadian cannabis stock with most of them burning significant investor wealth in the past year and the recent coronavirus pandemic seemed to have worsened thing. Industry operators have faced capital problems and most have been left grappling with debt. As a result,...
With the coronavirus ravaging the markets Canadian cannabis stocks have been some of the most effects. It is expected that we will see several losers but there will be some winners who will emerge after the COVID-19 pandemic strong. Even before the pandemic, the Canadian cannabis sector was performing...
Despite the legalization of recreational use, Canadian cannabis stocks have faced a myriad of challenges. Cannabis operators have faced regulatory challenges that have derailed the issuance of growing and retail store licenses with provinces such as Ontario lagging in retail store licensing which has caused a supply bottleneck in...
Canadian cannabis companies were expecting to capitalize on opportunities such as legalization of derivatives but it seems the COVID-19 pandemic will derail those opportunities. However, although there have been delays in the launch of derivatives and the opening of more stores the industry has benefitted from a surge in...